UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023586
Receipt number R000024678
Scientific Title Effect of both LAMA/LABA and smart watch for COPD patient about physical activity.
Date of disclosure of the study information 2016/08/11
Last modified on 2019/03/27 13:59:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of both LAMA/LABA and smart watch for COPD patient about physical activity.

Acronym

Matsusaka municipal hospital COPD study.

Scientific Title

Effect of both LAMA/LABA and smart watch for COPD patient about physical activity.

Scientific Title:Acronym

Matsusaka municipal hospital COPD study.

Region

Japan


Condition

Condition

COPD

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We are planning to conduct a test to see if physical activity will improve or not as we use LAMA/LABA and smart watch simultaneously.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We will evaluate physical activity using accelerator.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Applewatch
Tiotropium olodaterol mix

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1)A Patient who is visiting our outpatient clinic, is over 40 years of age, and has smoking history
2)A patient who is classified into the second or third stage of COPD in pulmonary function test.
3)A patient who smoke 1 pack per day for 10 years or more
4)A patient who agreed to participate in the study with the written informed consent

Key exclusion criteria

1)A patient who cannot be performed a respiratory function test appropriately
2) A patient whom the doctor in charge judged unsuitable as subjected is excluded.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Osamu
Middle name
Last name Hataji

Organization

Matsusaka Municipal Hospital

Division name

Respiratory Center

Zip code

5150073

Address

1550 Tonomachi,Matsusaka,Mie,515-8544,Japan

TEL

0598-23-1515

Email

mch1031@city-hosp.matsusaka.mie.jp


Public contact

Name of contact person

1st name Kie
Middle name
Last name Okamoto

Organization

Matsusaka Municipal Hospital

Division name

Respiratory Center

Zip code

5150073

Address

1550 Tonomachi,Matsusaka,Mie,515-8544,Japan

TEL

0598-23-1515

Homepage URL


Email

mchkuraguchi@city-hosp.matsusaka.mie.jp


Sponsor or person

Institute

Matsusaka Municipal Hospital

Institute

Department

Personal name



Funding Source

Organization

Matsusaka Municipal Hospital

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Matsusaka municipal hospital

Address

1550 Tonomachi Matsusaka Mie Japan

Tel

0509231515

Email

mch1031@city-hosp.matsusaka.mie.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 11 Day


Related information

URL releasing protocol

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658686/

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658686/

Number of participants that the trial has enrolled

20

Results

The mean number of steps and the mean energy expended in kilocalories for all patients were significantly
increased following treatment compared to the mean
values before treatment.

Results date posted

2019 Year 03 Month 27 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

COPD patients
GOLD 2 11
GOLD3 9

Participant flow

Explained Matsusaka municipal Hospital outpatients

Adverse events

non

Outcome measures

CAT
6MWT
FEV1
Physical activity level
steps

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 03 Month 01 Day

Date of IRB

2016 Year 03 Month 15 Day

Anticipated trial start date

2016 Year 03 Month 15 Day

Last follow-up date

2017 Year 01 Month 31 Day

Date of closure to data entry

2019 Year 03 Month 27 Day

Date trial data considered complete

2019 Year 03 Month 27 Day

Date analysis concluded

2019 Year 03 Month 27 Day


Other

Other related information



Management information

Registered date

2016 Year 08 Month 10 Day

Last modified on

2019 Year 03 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024678


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name